MLYS stock results show that Mineralys Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. More
Articles
BHIL Stock Earnings: Benson Hill Misses EPS, Misses Revenue for Q1 2024
BHIL stock results show that Benson Hill missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. More
CEVA Stock Earnings: CEVA Misses EPS, Misses Revenue for Q1 2024
CEVA stock results show that CEVA missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. More
ALGM Stock Earnings: Allegro Microsystems Beats EPS, Beats Revenue for Q4 2024
ALGM stock results show that Allegro Microsystems beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. More
VTRS Stock Earnings: Viatris Meets EPS, Misses Revenue for Q1 2024
VTRS stock results show that Viatris met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More
RPRX Stock Earnings: Royalty Pharma Misses EPS, Misses Revenue for Q1 2024
RPRX stock results show that Royalty Pharma missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. More
XERS Stock Earnings: Xeris Biopharma Holdings Misses EPS, Misses Revenue for Q1 2024
XERS stock results show that Xeris Biopharma Holdings missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. More
